7
25.11.2016 1 SIOG Presidential Session Etienne Brain, SIOG President 2014-2016 Stuart Lichtman, SIOG President-elect SIOG Presidential Session 11:30-11:40 Presidential address Stuart Lichtman (US) 11:40-11:50 SIOG 2016 Calabresi award Reinhard Stauder (AT) 11:50-12:00 SIOG 2016 Nursing & Allied Health award Etienne Brain (FR) and Stuart Lichtman (US) 12:00-12:10 SIOG 2016 Young Investigator award Etienne Brain (FR) and Stuart Lichtman (US) 12:10-12:20 SIOG 2016 Best Poster award Etienne Brain (FR) and Stuart Lichtman (US) 12:20-12:30 SIOG 2017 Annual Conference announcement Stuart Lichtman (US) Presidential Address Stuart M. Lichtman, MD Attending Physician 65+ Clinical Geriatrics Program Memorial Sloan Kettering Cancer Center Professor of Medicine, Weill Cornell Medical College President, International Society of Geriatric Oncology 11/19/16 Disclosure No conflict of interest My thank you’s… Thank you for this great honor… We all need help along the way…. Thank you to Etienne…

SIOG Presidential Session

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: SIOG Presidential Session

25.11.2016

1

SIOG Presidential Session

Etienne Brain, SIOG President 2014-2016

Stuart Lichtman, SIOG President-elect

SIOG Presidential Session11:30-11:40 Presidential address

Stuart Lichtman (US)11:40-11:50 SIOG 2016 Calabresi awardReinhard Stauder (AT)

11:50-12:00 SIOG 2016 Nursing & Allied Health awardEtienne Brain (FR) and Stuart Lichtman (US)12:00-12:10 SIOG 2016 Young Investigator award

Etienne Brain (FR) and Stuart Lichtman (US)12:10-12:20 SIOG 2016 Best Poster awardEtienne Brain (FR) and Stuart Lichtman (US)12:20-12:30 SIOG 2017 Annual Conference announcement

Stuart Lichtman (US)

Presidential Address

Stuart M. Lichtman, MDAttending Physician

65+ Clinical Geriatrics Program

Memorial Sloan Kettering Cancer Center

Professor of Medicine, Weill Cornell Medical College

President, International Society of Geriatric Oncology

11/19/16

Disclosure

No conflict of interest

My thank you’s…

• Thank you for this great honor…

• We all need help along the way….

Thank you to Etienne…

Page 2: SIOG Presidential Session

25.11.2016

2

Thank you to former Presidents…

• 2000-2002 - Paul Calabresi (USA)

• 2002-2004 - Silvio Monfardini (Italy)

• 2004-2006 - Harvey Cohen (USA)

• 2006-2008 - Jean-Pierre Droz (France)

• 2008-2010 - Martine Extermann (USA)

• 2010-2012 - Riccardo Audisio (UK)

• 2012-2014- Arti Hurria (USA)

• 2014-2016- Etienne Brain (France)

Special Thanks…

Lodovico Balducci, MD Matti Aapro, MD

SIOG

• Thank you

– To the membership

– To the SIOG staff

• Laurence Verhagen

• Laurence Jocaille

• Sabrina Marchal

– To the SIOG Board and Executive Committee

– My colleagues at Memorial Sloan Kettering Cancer Center

We’ve come a long way… Where we’ve been

• 1980s: what’s geriatric oncology?

• 1990s: sounds interesting; maybe we should review what is

known

• 2000s: lets start doing studies and study patient outcomes

• 2010s: we are starting to learn about older cancer patients

and how to treat them

• 2016s: we know a lot, but need to know more; we are great

at predicting; we have to intervene and prove the

benefit

Page 3: SIOG Presidential Session

25.11.2016

3

Perceptions of aging has changed…

Negative Elder Stereotypes

• Elders are portrayed as helpless victims

• Elders who defy negative stereotypes are presented as bizarre and comical

• Growing old is equated with inevitable deterioration and decline

• Elders are demonized as a group

• Elders are under-represented and ignored

http://www.agingwatch.com/?p=439

Positive ImagesSIOG Priorities

• Viability of the organization

– Increase SIOG membership with emphasis on trainees; need to

emphasize the value of membership

– Funding

• Newer models are needed

• Incorporate geriatric oncology principles into routine practice

• Raise professional awareness of geriatric oncology and SIOG

Viability of the organization

• Increasing membership

– Maintain current members

– Bringing in new member particularly trainees

– We need to ‘sell’ the idea that all adult oncologist are geriatric

oncologists; this is particularly true to those feel that GO is irrelevant

to their practice

• Demographics should sell itself

• Problem: too little time, too many organizations and memberships; benefits

without membership

Annual MeetingAttendance

Issues

• Only 1/3 of attendees are members

• Need to increase trainees and NAH

members

• 2016: 457 delegates

Members – 210

Trainees + NAH - 64

• 2015: 426 delegates

Members - 144

Trainees + NAH – 51

• 2014: 361 delegates

Members - 147

Trainees + NAH – 57

• 2013: 346 delegates

Members - 143

Trainees - 23

NAH - 38

Page 4: SIOG Presidential Session

25.11.2016

4

Incorporate geriatric oncology principles

into routine practice

• Why do I need to know Geriatric Oncology; I know how to take

care of older patients…

– Show that developing predictive models add to or are better than

clinical judgment, i.e. CARG and CRASH scores

– Performance status does not correlate with functional status

– Much of the assessment can be self administered or with help; role

of technology; does not have to be time consuming or complicated

Raise professional awareness of

geriatric oncology and SIOG

• ASCO, ESMO, EONS, ONS, etc etc

– Have to actively participate and be advocates

• Grass roots efforts in home institutions

• Encourage fellows

2015

Research in the Elderly

Conclusions

• Our role is to be the advocates for the older cancer patients

– Patient care role

– Academically

• Convince colleagues of its importance as the central focus of

oncology

• Maintain and enhance vitality of SIOG

• Influence research initiatives

Page 5: SIOG Presidential Session

25.11.2016

5

All Adult Oncologists are Geriatric Oncologists…

This is no longer a niche field of a few dedicated researchers…

Thank you

It is my privilege to be your colleague and

President of SIOG so we can continue our

important work together

2016 Paul Calabresi Award

2016 Recipient

Reinhard StauderDepartment of Internal Medicine V (Haematology and Oncology),

Innsbruck Medical University, Innsbruck, Austria

Dr. Reinhard StauderAssociate Professor at the Department of Internal Medicine V (Haematology and

Oncology), Innsbruck Medical University, Innsbruck, AustriaReinhard Stauder received his Doctoral Degree in Medicine in 1981 from the University of Innsbruck and in

2006 received a Master's Degree in Health Sciences from the University of Health Sciences, Medical

Informatics and Technology, Hall in Tirol, Austria. From 1994 – 1996, he was Scientific Member at the Basel

Institute for Immunology, Basel, Switzerland.

RS is a specialist in Internal Medicine, a Certified Specialist in Hematology and Oncology and Associate

Professor of Medicine at Innsbruck Medical University, Austria. His main clinical and scientific focus lies in

Myelodysplastic Syndromes (MDS), in geriatric oncology and in anemia in the elderly. His main goal is the

development of individualized treatment algorithms in elderly cancer patients.

At present RS is responsible for the geriatric oncology and MDS program of the Department of Internal

Medicine V (Haematology and Oncology), Innsbruck Medical University. RS is a member of the European

Leukemia Net (ELN) and is representative of Austria in the European LeukemiaNet MDS registry (EU-MDS).

RS is a member of the board of the Austrian Society for Haematology and Oncology (OEGHO) as well as

vice-chairman of the Austrian MDS-Plattform and chairman of the Geriatric Oncology Group of the OEGHO.

RS is the National Representative for Austria in the International Society of Geriatric Oncology (SIOG), is

editorial board member of “The Journal of Geriatric Oncology” and is founder and chairman of the Austrian

association „Aid in elderly cancer patients” (Verein Senioren-Krebshilfe). In addition RS is a member of the

Scientific Working Groups on Hematology and Ageing of EHA and ASH.

RS is author of numerous scientific publications including more than 95 publications in peer-reviewed

journals.

SIOG 2016 Nursing & Allied

Health Investigators Award

Fay StrohscheinCanada

Fay Strohschein PhD Candidate, Nursing Clinical Consultant, McGill University,

Ingram School of Nursing, Montreal, Canada

Fay Strohschein is a PhD candidate at the Ingram School of Nursing, McGillUniversity, in Montreal, Canada. Her research interest in treatment decision making

among older adults with cancer grew out of her clinical work with the ConsultationService for Senior Oncology Patients at the Jewish General Hospital, also in

Montreal. She has worked as a Nursing Clinical Consultant/Nurse Navigator with this

program since its inception in 2006. Throughout her studies, Fay has held fellowshipswith the Quebec Network for Research on Aging and the Psychosocial Oncology

Research Training Program, funded by the Canadian Institutes of Health Research.Her dissertation study was funded through an Oncology Nursing Foundation (USA)

Research Grant and a Fonds de recherché du Québec - Santé Doctoral TrainingAward.

O12 - Choosing to trust: cancer treatment decision making from theperspective of older adults with colorectal cancer.

Page 6: SIOG Presidential Session

25.11.2016

6

SIOG 2016

Young Investigators Award

Zachary HorneUnited States of America

Zachary HorneUnited States of America

Zachary D. Horne studied medicine at The George Washington University (UnitedStates) and received his medical degree in 2013. He is now a fourth year resident in

Radiation Oncology at The University of Pittsburgh Cancer Institute. He anticipates acareer in academic radiation oncology to continue pursuing research within the field

with special attention to the geriatric population both in terms of patient outcomes and

the cognitive/psychosocial effects of cancer and radiation therapy. His other researchinterests include the utilization of stereotactic ablative radiotherapy for early stage

lung cancer and oligometastatic disease and the emotional/cognitive impacts ofgynecologic brachytherapy.

O02 - National patterns of care and outcomes of oropharyngeal squamouscell carcinomas in patients over 70.

SIOG 2016 Best Poster Award

Daisuke MakiuraP051 - Sarcopenia is associated with an unplanned

readmission and worse survival following

esophagectomy

Text

Program Committee

Page 7: SIOG Presidential Session

25.11.2016

7

Theme

• From research to practice: incorporating geriatric oncology

into patient care

Conference

• Case based discussion as a component of meeting

• Some change in meeting structure

• Opportunity to contribute ideas for sessions

• Opportunity to present research findings

Key dates

• Opening of registration and abstract submission - Tuesday,

April 4, 2017

• Abstract Submission deadline - Thursday, June 8, 2017

• Early Registration deadline - Tuesday, June 20, 2017

• SIOG 2017 Conference - November 8-11, 2017

Grazie&

See you in Warsaw!